Sydney Morning Herald 1:52pm: West Texas Intermediate crude fluctuated near a two-day high on speculation that sustained growth in China will bolster fuel demand in the world's second-largest oil consumer. Futures swung between gains and losses in New York after capping a ... and more »
Wall Street Journal (press release) "Today's announcement continues that trend with the appointment of a Lead Director. I am grateful for Mr. Loeb's willingness to assume this new position as we strive for ... ABOUT AMERICAN PACIFIC CORPORATION. American Pacific Corporation (AMPAC) is a ... and more »
Seeking Alpha These trends add up to a picture of prevailing volatility and uncertainty in the global economy. In Q2 2013, BASF successfully maneuvered through this ... In Intermediates , sales decreased against a strong basis of comparison. Prices came under ...
Business Recorder (blog) Last year, China surpassed the US to become the world's biggest trading nation as per China's customs administration data suggesting country's trade in goods in 2012 at $3.87 trillion. Consequently, China's growing influence in ..... Overall, the ... and more »
Fortune (blog) His boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, had joined the generic- drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and ... and more »
The Biological SCENE Likewise, Switzerland's Evolva is working with IFF to scale up a process to make vanillin , the key ingredient of vanilla, via fermentation rather than by extraction or chemical synthesis. Evolva also works with BASF on the biosynthesis of natural ...
Healthcare Packaging His boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, had joined the generic- drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and ...
4-traders (press release) "We remain on target for implementation of our key growth-based capital projects, including the large investment at our Iowa facility to expand overall capacity and to make commercial launch material pursuant to a supply agreement signed in 2012 ... and more »
PharmaLive (press release) (subscription) This increase was primarily due to higher custom development sales related to clinical phase projects and higher sales of certain active pharmaceutical ingredients for branded commercial products. .... provide examples of such risks and uncertainties ...
Seeking Alpha Custom manufacturing, which include APIs, intermediates and other pharmaceutical products sold to innovative pharmaceutical companies, increased $3.3 million or 14% in the first quarter, compared to the same quarter last year, excluding the impact of ... and more »
